Evidence map›Paper›PMID 28918477›Full record

ArticleVirologica Sinica2017

In vitro inhibition of HIV-1 replication in autologous CD4

Ting Tu, Jianbo Zhan, Danlei Mou, Wei Li, Bin Su, Tong Zhang, Tao Li, Ning Li, Hao Wu, Cong Jin and 1 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Virologica Sinica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 89% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Ting TuJiangsu Key Laboratory of Clinical Laboratory Medicine, Jiangsu University School of Medicine, Zhenjiang, 212013, China.
Jianbo ZhanHubei Provincial Center for Disease Control and Prevention, Wuhan, 430079, China.
Danlei MouBeijing You'an Hospital, Capital Medical University, Beijing, 100069, China.
Wei LiBeijing You'an Hospital, Capital Medical University, Beijing, 100069, China.
Bin SuBeijing You'an Hospital, Capital Medical University, Beijing, 100069, China.
Tong ZhangBeijing You'an Hospital, Capital Medical University, Beijing, 100069, China.
Tao LiJiangsu Key Laboratory of Clinical Laboratory Medicine, Jiangsu University School of Medicine, Zhenjiang, 212013, China.
Ning LiBeijing You'an Hospital, Capital Medical University, Beijing, 100069, China.
Hao WuBeijing You'an Hospital, Capital Medical University, Beijing, 100069, China.
Cong JinNational HIV/HCV Reference Laboratory, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China. jincongbj@163.com.ORCID http://orcid.org/0000-0002-5200-5992
Huabiao ChenJiangsu Key Laboratory of Clinical Laboratory Medicine, Jiangsu University School of Medicine, Zhenjiang, 212013, China. chenhuabiao@hotmail.com.ORCID http://orcid.org/0000-0002-7215-5429
Capital Medical University · CNJiangsu University · CNHubei Provincial Center for Disease Control and Prevention · CNNational Center for AIDS/STD Control and Prevention,China CDC · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HIV-1-specific cytotoxic T lymphocytes (CTLs) and neutralizing antibodies (NAbs) are present during chronic infection, but the relative contributions of these effector mechanisms to viral containment remain unclear. Here, using an in vitro model involving autologous CD4

Indexed as

Virus ReplicationAntibodies, MonoclonalAntibodies, NeutralizingAntibody-Dependent Cell CytotoxicityCD4-Positive T-LymphocytesCells, CulturedHIV-1HIV AntibodiesHumansKiller Cells, NaturalT-Lymphocytes, CytotoxicAntibodies, MonoclonalAntibodies, NeutralizingHIV Antibodiescytotoxic T lymphocyte (CTL)HIV-1 infectionnatural killer cellsneutralizing antibodyviral replication

Identifiers

PMID28918477
PMCPMC6599175
OpenAlexW2755726863

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.